Comment by
HotDiggityDogg on Feb 03, 2022 12:28pm
This is encouraging news. I think WELL's assets such as WISP and Circle could end up in a similar way but not sure about the clinics. As you have said many times I think CEO having divided the assets into two groups had the same plan which is to ultimately sell each division off. ( hopefully for top premium )
Comment by
monty613 on Feb 03, 2022 1:17pm
the clinics are extremely valuable. in the private marketplace, companies like this trade for 10X-15X EBITDA because they are stable, profitable, high margin cashflow generating businesses. there is lots of consolidation happening in the healthcare services space. healthcare is also extremely defensive and these assets would be attractive to a PE player looking for a defensive play.
Comment by
HotDiggityDogg on Feb 03, 2022 1:34pm
Ok. Can you take an educated guess as to what the combined value of both types of assets would be for WELL? In case CEO was offered a buyout by different buyers for each part ( virtual and patient services ?)
Comment by
HotDiggityDogg on Feb 03, 2022 3:10pm
This makes perfect sense. Thanks for taking the time to write it up. I'm slowly picking up more shares and seeing some encouraging signs an an otherwise horrible market. ( for well ). My guess is that I'm not the only one and more investors will start to notice what I am noticing. I will be more than happy with a sale of 7-8$ per share if it ever happened. Cheers
Comment by
speedy99 on Feb 04, 2022 11:04am
Hotdog, if Scotia is right and in the longer view we will be approaching a 1 Billion top line run rate, I think we can all agree that this will change market sentiment in our favour. With a 5 to 1 enterprise value to sales, we could anticipate a modest 5 billion market cap for WELL. That's the kind of thing I am waiting for, not a lousy $7.00 share price.
Comment by
HotDiggityDogg on Feb 04, 2022 11:29am
I will be very happy to see such market cap but unless the Fed reverses course I don't see those multiples. Also if we go by Scotia's report then wouldn't it make sense to take their 12 month price target as accurate also ? Personally I don't think these reports are anything other than hype. Very same analysts had said WELL is 12$ in 12 months only 3 months ago. Cheers
Comment by
bandit69 on Feb 04, 2022 1:51pm
I've never seen an analyst that has been correct in all my time in the markets. They all have an agenda hence the titles "buy side" or "sell side" analysts.
Comment by
brandinvestor on Feb 04, 2022 3:07pm
Don't forget they also look at market conditions and comparibles. WELL last year compared to it's competition was worth $10-$12 but the entirety of Health Tech is down which means comparibly we are worth $8 now compared to the competition's comparibles.
Comment by
bandit69 on Feb 04, 2022 11:36am
a modest 5 billion ....HAHA. Sure. :)